Disease Info Card

Hereditary Hemorrhagic Telangiectasia

Information about Hereditary Hemorrhagic Telangiectasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hereditary Hemorrhagic Telangiectasia

Most recent studies have shown that Hereditary Hemorrhagic Telangiectasia shares some biological mechanisms with abscess, anemia, aneurysm, angiomatosis, arteriovenous-fistula, arteriovenous-malformation, brain-abscess, dysplasia, epistaxis, gastrointestinal-hemorrhage, hemangioma, hemorrhage, hypertensive-disease, liver-diseases, neoplasms, pathologic-fistula, pulmonary-arteriovenous-fistula, telangiectasis, vascular-anomaly, vascular-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hereditary Hemorrhagic Telangiectasia, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Death, Cell Growth, Cell Migration, Cell Proliferation, Coagulation, Cyclooxygenase Pathway, Drug Resistance, Endothelial Cell Migration, Hemostasis, Induction Of Apoptosis, Lipoxygenase Pathway, Localization, Pathogenesis, Platelet Activation, Platelet Aggregation, Secretion, Translation, Vasculogenesis

Quite a number of genes have been found to play important roles in Hereditary Hemorrhagic Telangiectasia, such as ACVRL1, ATP6V0A2, BMPR2, CTLA4, ENG, GDF2, GPHA2, HLA-DQA1, HPGDS, NOD2, PLEKHM1, PTGDS, SGCA, SLPI, SMAD4, TEAD1, TGFB1, TGFBR1, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.